Title:Photodynamic Therapy: The Light Treatment for Cutaneous Non- Melanoma Malignancies
Volume: 12
Issue: 2
Author(s): Edward Yu
Affiliation:
Keywords:
Non-melanoma, photodynamic therapy, photosensitizers, skin cancer, treatment.
Abstract: Photodynamic therapy has many treatment applications for malignant and premalignant
lesions of the skin. The basic principle involves application of a photosensitizer
followed by exposure of the target tissues to light. 5-aminolevulinic acid is a natural occurring
compound in the heme biosynthesis pathway. Its metabolite protoporphyrin IX is a
photosensitizer that has the ability to selectively damage premalignant, malignant, and certain
abnormal tissues, rendering its wide application for use in actinic keratosis, Bowen’s
disease, and basal cell carcinoma. Adequate lesion preparation is critical for successful
treatment. Ongoing research on the clinical use of photodynamic therapy, its potential impact
in oncological patient management and on public health and cost is continuously
evolving. The perfection of this light therapy on patient treatment awaits results of future
clinical trials.
